Martin T, Richardson PG, Facon T, Moreau P, Perrot A, Spicka I, Bisht K, Inchauspé M, Casca F, Macé S, van de Velde H, Suzuki K. Primary outcomes by 1q21+ status for isatuximab-treated patients with relapsed/refractory multiple myeloma: subgroup analyses from ICARIA-MM and IKEMA. haematol [Internet]. 2022Oct.1 [cited 2024Apr.26];107(10):2485-91. Available from: https://haematologica.org/article/view/haematol.2022.280660